Our Latest Insights

Show filters

Blog

-

Blog

The Next Era of Emids

For the last 23 years, Emids has been built on innovation and the relentless pursuit of excellence. We have experienced incredible growth, with more than 3,300 associates and a footprint in six countries on four continents. Our customers span the healthcare ecosystem, including providers, payers, life science companies and technology firms. As a result of […]

Blog

-

Blog

Keeping Up With A Shifting Healthcare Landscape: Emids Healthcare Summit 2021 Review

Like every facet of our lives, healthcare has experienced dramatic shifts due to the pandemic. What we thought was normal—from how we work, to how we learn, to how we access healthcare—has been disrupted. In healthcare specifically, we’re seeing more organizations joining forces to tackle new challenges popping up in the healthcare landscape. During the […]

Blog

-

Blog

Must-See Panels at The 8th Annual Emids Healthcare Summit

The ultimate guide to the 8th Annual emids Healthcare Summit. Bookmark your favorite sessions and prepare for exclusive conversations, networking and learning.

Blog

-

Blog

A Look at the Finalized 2022 IQR and PI Programs

CMS dropped the 2022 IPPS Final Rule and made changes to the 2022 IQR and PI program requirements. Here’s what you need to know.

Blog

-

Blog

Healthcare’s Mashup: Turning The Unexpected Into Progress

From laggard to leader. How healthcare’s mashup of organizations, technologies, care delivery and payment models is moving the industry forward.

Blog

-

Blog

Enhancing the Telehealth Footprint and Avoiding the Telehealth Cliff

Discover how leveraging digital tools, operational changes and collaboration with new entities is central to transforming care services and improving outcomes.

Blog

-

Blog

No Surprises Act Interim Final Rule: Understanding the Implications

A clear path to evaluating, designing and implementing a custom compliance solution with a broad range of payer and provider services is essential under the IFC.

Blog

-

Blog

Life Sciences

Healthcare’s 2021 Midyear Outlook

Halfway into 2021, we step back in retrospect to review healthcare’s progress.

Blog

-

Blog

Changing the Game: Growing our Purpose Post-Pandemic

A message on purposeful growth and post-pandemic healthcare from our Chief Strategy Officer.

Blog

-

Blog

Life Sciences

Clinical Trial Disclosure and Data Transparency

To create value in the clinical trial space, biopharmaceutical companies must overcome three key barriers to full disclosure and data transparency.

Blog

-

Blog

Design Thinking

Modernize Technology: Pushing The Boundaries of Digital

Despite 2020 being a sink-or-swim year, healthcare raised record-breaking funding rounds, experienced unparalleled levels of M&A and increased the adoption of virtual care. Throughout the pandemic, healthcare pushed beyond the boundaries of any single technology to deliver care. Whether a leader or laggard, healthcare organizations doubled down on leveraging technology when the pandemic amplified the […]

Blog

-

Blog

Here We Go Again: The Historic Consolidated Appropriations Act, 2021 – Are You Ready for January 1, 2022?

On December 27, 2020, the Consolidated Appropriations Act, 2021 was signed into Law. As the enactment timing was during the holiday season, the Act could be compared to a fruitcake; you may want to avoid it because of the suspect dried fruit, but yet the yummy spirits-soaked cake pulls you in.  Referred to as the fifth longest […]

Sign up to receive our latest insights